Andon Health Hits Day High with Strong 5.74% Intraday Surge

Andon Health Co., Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in its stock price, gaining 5.74% on March 10, 2026. The stock reached an intraday high of CNY 53.70, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index only increased by 0.65% on the same day. Over the past week, Andon Health has shown a 5.35% increase, and its one-month performance stands at an impressive 25.89%, significantly outpacing the Shanghai Composite, which has seen a slight decline of 0.13%. Year-to-date, the company has achieved a remarkable 32.87% growth, while the index has only managed a 3.89% increase. Despite these positive short-term trends, Andon Health has faced challenges in its financial performance, including a significant decline in operating profit and negative results over the past nine quarters. The company reported a net profit of CNY 162.69 million, reflecting a decrease of 69.23%. With a market capitalization of CNY 18,799 million, Andon Health continues to navigate a complex financial landscape while maintaining a competitive position in its industry.